Drugs / Wound Healing Gel
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT07311057 Background | Dec 2025 → Jan 2026 overdue | skin squamous cell carcinoma | Daryoush Hamidi Alamdari, PhD | Enrolling by invitation | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Wound Healing Gel | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07311057 ↗ |
| Route | Topical | “Following completion of the methylene blue treatment, a wound healing gel will be applied to the treated lesions” NCT07311057 ↗ |